Published in Clin Biochem Rev on November 01, 2013
Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology (2014) 1.73
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents. Int J Endocrinol (2016) 1.40
Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer. PLoS One (2016) 0.80
Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Int J Endocrinol (2015) 0.80
Increased liver markers are associated with higher risk of type 2 diabetes. World J Gastroenterol (2015) 0.78
Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL/Ly lymphoma-bearing mice. Croat Med J (2016) 0.77
The Rat microRNA body atlas; Evaluation of the microRNA content of rat organs through deep sequencing and characterization of pancreas enriched miRNAs as biomarkers of pancreatic toxicity in the rat and dog. BMC Genomics (2016) 0.77
The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma. Int Urol Nephrol (2017) 0.77
Prolonged expression of secreted enzymes in dogs after liver-directed delivery of <i>Sleeping Beauty</i> transposons: implications for non-viral gene therapy of systemic disease. Hum Gene Ther (2017) 0.76
Citrate functionalized Mn3O4 in nanotherapy of hepatic fibrosis by oral administration. Future Sci OA (2016) 0.75
Review and Recommendations for the Component Tests in the Liver Function Test Profile. Indian J Clin Biochem (2015) 0.75
Association between Plasmatic Ceramides Profile and AST/ALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of Obesity. Can J Gastroenterol Hepatol (2017) 0.75
Emerging concepts in alcoholic hepatitis. World J Hepatol (2017) 0.75
The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine (Baltimore) (2016) 0.75
Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease. Antimicrob Agents Chemother (2016) 0.75
Relation between Liver Transaminases and Dyslipidaemia among 2-10 y.o. Northern Mexican Children. PLoS One (2016) 0.75
Mitochondrial DNA 5178 C/A polymorphism modulates the effects of coffee consumption on elevated levels of serum liver enzymes in male Japanese health check-up examinees: an exploratory cross-sectional study. J Physiol Anthropol (2016) 0.75
The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients. Int Urol Nephrol (2017) 0.75
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model. Oncotarget (2017) 0.75
Limited Excessive Voluntary Alcohol Drinking Leads to Liver Dysfunction in Mice. Alcohol Clin Exp Res (2017) 0.75
The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy. Int Urol Nephrol (2017) 0.75
De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke. Neuropsychiatr Dis Treat (2017) 0.75
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology (2003) 16.40
The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology (2005) 15.74
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology (1999) 11.76
Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med (2002) 10.78
Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology (2006) 10.05
The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol (2003) 8.23
Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med (2000) 7.97
Public health: The toxic truth about sugar. Nature (2012) 6.24
Transaminase activity in human blood. J Clin Invest (1955) 5.98
Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med (2008) 5.27
Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology (2003) 4.95
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology (2003) 4.84
Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology (2009) 4.82
Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology (2002) 4.34
Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med (2013) 3.39
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86
Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol (2004) 2.78
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology (2008) 2.70
Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem (2000) 2.47
GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther (2007) 2.41
Muscular exercise can cause highly pathological liver function tests in healthy men. Br J Clin Pharmacol (2007) 2.30
The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol (1999) 2.18
The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol (2006) 2.13
The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci (1979) 2.12
Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol (2001) 2.04
AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1998) 1.97
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology (1988) 1.91
High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol (2004) 1.80
Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med (2003) 1.80
Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem (2001) 1.69
Serum alanine aminotransferase in skeletal muscle diseases. Hepatology (2005) 1.54
Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults. Am J Gastroenterol (2000) 1.51
Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci (2007) 1.49
Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients. Am J Gastroenterol (2001) 1.44
Alcohol consumption guidelines: relative safety vs absolute risks and benefits. Lancet (1995) 1.43
Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem (1975) 1.39
Dietary fructose in nonalcoholic fatty liver disease. Hepatology (2013) 1.39
Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury. J Med Toxicol (2010) 1.33
The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem (2011) 1.31
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol (2011) 1.29
Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med (1983) 1.28
Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin Chem (1978) 1.27
Fructose as a key player in the development of fatty liver disease. World J Gastroenterol (2013) 1.26
Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome. World J Gastroenterol (2012) 1.19
Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther (2009) 1.19
Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies. Curr Opin Lipidol (2013) 1.17
[Transaminase activity of human serum in viral hepatitis; preventive note]. Minerva Med (1955) 1.16
Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology (1985) 1.14
Serum enzyme activities in individuals with different levels of physical fitness. J Sports Med Phys Fitness (1993) 1.11
Body weight, alcohol consumption and liver enzyme activity--a 4-year follow-up study. Int J Epidemiol (2001) 1.09
[Methods and value of determination of glutamic acid dehydrogenase activity in the serum. A contribution to the importance of examination of enzyme relations in the serum]. Klin Wochenschr (1962) 1.07
An enzymic test for the diagnosis of viral hepatitis; the transaminase serum activities. Clin Chim Acta (1957) 1.07
The clinical significance of alterations in transaminase activities of serum and other body fluids. Adv Clin Chem (1958) 1.06
Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection. Liver Int (2006) 1.06
Two or more synchronous combination of noninvasive tests to increase accuracy of liver fibrosis assessement in chronic hepatitis C; results from a cohort of 446 patients. Hepat Mon (2012) 1.05
Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma. Intern Med (2008) 1.03
Hepatic transaminase activity in alocholic liver disease. Gastroenterology (1980) 1.03
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. Scand J Gastroenterol (1997) 1.02
Does fructose consumption contribute to non-alcoholic fatty liver disease? Clin Res Hepatol Gastroenterol (2012) 1.01
Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology (1984) 1.00
Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis? J Gastroenterol Hepatol (2000) 0.99
Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One (2012) 0.99
Non-alcoholic steatohepatitis with normal aminotransferase values. World J Gastroenterol (2009) 0.99
The value of gamma-glutamyl transpeptidase as a screen test for liver tumour. Acta Chir Scand (1970) 0.98
Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1α/cJun to enhance plasma ALT/AST. J Biol Chem (2013) 0.97
Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology (1984) 0.96
Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption. J Gastroenterol Hepatol (2008) 0.95
Prognostic value of liver fibrosis biomarkers: a meta-analysis. Gastroenterol Hepatol (N Y) (2011) 0.95
Elevated SGOT/SGPT ratio in alcoholic patients with acetaminophen hepatotoxicity. Am J Gastroenterol (1984) 0.95
Anicteric virus hepatitis in a closed environment as shown by serum transaminase activity. Bull World Health Organ (1959) 0.95
Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients. Enzyme (1986) 0.94
Relationships between alanine aminotransferase levels, abnormal liver echogenicity, and metabolic syndrome. J Am Board Fam Med (2011) 0.94
Role of simple biomarkers in predicting fibrosis progression in HCV infection. World J Gastroenterol (2010) 0.93
Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men. World J Gastroenterol (2007) 0.93
Relationship between alcohol drinking and aspartate aminotransferase:alanine aminotransferase (AST:ALT) ratio, mean corpuscular volume (MCV), gamma-glutamyl transpeptidase (GGT), and apolipoprotein A1 and B in the U.S. population. J Stud Alcohol Drugs (2010) 0.92
Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit. Hepatology (1986) 0.92
Multiple serum enzyme analyses in chronic alcoholics. Acta Med Scand (1970) 0.92
Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol (2012) 0.92
Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. Health Technol Assess (2012) 0.91
[Reestimation of aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio based on JSCC consensus method--changes of criteria for a differential diagnosis of hepatic disorders following the alteration from Karmen method to JSCC method]. Nihon Shokakibyo Gakkai Zasshi (1994) 0.91
THE VALUE OF GAMMA-GLUTAMYL TRANSPEPTIDASE IN DIFFERENTIATING VIRAL HEPATITIS FROM OBSTRUCTIVE JAUNDICE. A STATISTICAL COMPARISON WITH ALKALINE PHOSPHATASE. Acta Chir Scand (1965) 0.90
AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig Dis Sci (1998) 0.88
Carbohydrate intake and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care (2013) 0.88
Use of enzymes for the diagnosis of alcohol-related organ damage. Enzyme (1987) 0.86
Delivery as "physiological stress" and its influence on liver enzymatic systems in asphyxial newborns. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2005) 0.86
Mathematical and computer-assisted procedures in the diagnosis of liver and biliary tract disorders. Adv Clin Chem (1978) 0.86
[ENZYME DETERMINATIONS IN THE SERUM IN LIVER DISEASES. FUNCTION PATTERNS AS A MEANS OF DIAGNOSIS]. Enzymol Biol Clin (Basel) (1963) 0.86
The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am J Gastroenterol (2002) 0.86
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin Chem (2001) 0.86
Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity. Toxicol Appl Pharmacol (2009) 0.85
Plasma creatine kinase/aspartate aminotransferase ratio in the diagnosis of acute myocardial infarction. Clin Chem (1985) 0.85
Independent and supra-additive effects of alcohol consumption, cigarette smoking, and metabolic syndrome on the elevation of serum liver enzyme levels. PLoS One (2013) 0.85
Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level. Alcohol Alcohol (2005) 0.85
High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis. Liver Int (2007) 0.84
Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Ann Clin Biochem (2005) 0.84
[Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis]. Korean J Gastroenterol (2004) 0.84